Metastatic Hormone Sensitive Prostate Cancer (2)

Active, not recruiting (2)

phase 3 (2)

Astellas Pharma China, Inc. (1)

Astellas Pharma Global Development, Inc. (1)

Medivation LLC, a wholly owned subsidiary of Pfizer Inc. (1)

enzalutamide (2)

placebo (2)

androgen deprivation therapy (adt) (1)

drug (2)

Industry (2)

Interventional (2)

metastatic hormone sensitive prostate cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Jan 7, 2023

Active, not recruiting

Jul 29, 2022